US 11,883,420 B2
Sting agonists for treating bladder cancer and solid tumors
Brian F. McGuinness, Plainsboro, NJ (US); Grant Gallagher, Milltown, NJ (US); Michael S. McQueney, Philadelphia, PA (US); Rukiye Nazan Eraslan, Robbinsville, NJ (US); Gary Schieven, Lawrenceville, NJ (US); Jason Trama, Cream Ridge, NJ (US); Axel Metzger, Jackson, NJ (US); David J. Diller, East Windsor, NJ (US); and David E. Kaelin, Helmatta, NJ (US)
Assigned to VENENUM BIODESIGN, LLC, Hamilton, NJ (US)
Filed by Venenum Biodesign, LLC, Hamilton, NJ (US); and Catherine C. McGuinness, Plainsboro, NJ (US)
Filed on Jun. 8, 2021, as Appl. No. 17/342,170.
Application 17/342,170 is a division of application No. 17/096,416, filed on Nov. 12, 2020, granted, now 11,110,106.
Application 17/096,416 is a continuation in part of application No. 16/662,980, filed on Oct. 24, 2019, granted, now 11,161,864.
Claims priority of provisional application 62/785,711, filed on Dec. 28, 2018.
Claims priority of provisional application 62/751,769, filed on Oct. 29, 2018.
Prior Publication US 2021/0290645 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/519 (2006.01); A61K 31/688 (2006.01); A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01)
CPC A61K 31/688 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0034 (2013.01); A61K 9/08 (2013.01); A61K 31/519 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01)] 4 Claims
 
1. A method for treating solid tumors comprising administering to a patient in need of treatment for a solid tumor a therapeutically effective amount of a compound of formula 1

OG Complex Work Unit Chemistry
or pharmaceutically acceptable salt thereof.